NCT04505696

Providing Speech Therapy Awareness in Private Schools

Completed NA Last updated 8 October 2020

What this trial tests

NA trial testing Speech-Language Pathology Presentation in Speech and Language Disorder in 138 participants. Completed in 15 September 2020.

Timeline

5 August 2020

Primary endpoint
15 September 2020

15 September 2020

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	138
Start date	5 August 2020
Primary completion	15 September 2020
Estimated completion	15 September 2020
Sites	1 location across Pakistan

Drugs / interventions tested

• Speech-Language Pathology Presentation

Conditions studied

• Speech and Language Disorder — all drugs for Speech and Language Disorder →
• Speech Therapy — all drugs for Speech Therapy →
• Speech Delay — all drugs for Speech Delay →
• Swallowing Disorder — all drugs for Swallowing Disorder →

Sponsor

Riphah International University

Who can join

Eligibility, any sex, with Speech and Language Disorder or Speech Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There has been limited research in the area of speech and language therapy awareness in Pakistan. The study aims to assess the efficacy of providing speech therapy awareness in private schools through a pre-post model. This Quasi experimental study will be a means of reaching out to schools and directly create awareness regarding the field and its scope. Pre-assessment will be carried out and after which a 45 minutes presentation will be conducted face to face or through a webinar as per school directives. The results will be analysed quantitatively and pre-post assessment of the participants will be measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.